Dr. Mark Little

Senior Vice President, Prescient Intelligence & Insight

The third annual white paper on the strategic imperatives in CI is out now.

Competitive intelligence (CI) is fundamental to ensuring the success of pharmaceutical companies, whether they are developing a new drug or are already an established presence in the market.

Alongside research and development (R&D), CI is crucial to businesses that want to maximize the value of their science.

Now in its third year, Prescient has spoken to more key players in CI from across the pharmaceutical industry than ever before. From established players to the industry’s most innovative disruptors, Prescient has gathered a group of world experts to give insights on the trends and challenges faced by CI professionals today.

Download this white paper to learn:

  • The top 10 challenges for CI professionals in 2021
  • How the landscape has changed since our previous survey in 2020
  • Strategies and responses appropriate for a post-COVID-19 world

The 2021 Strategic Imperatives in Competitive Intelligence white paper is your unmissable guide to the issues that will shape CI in the pharmaceutical industry as we enter 2022 – download your free copy by submitting the following form.